A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies

1994 ◽  
Vol 6 (3) ◽  
pp. 263-266 ◽  
Author(s):  
Garth A. Nicholson ◽  
Linda J. Valentijn ◽  
Annia K. Cherryson ◽  
Marina L. Kennerson ◽  
Tara L. Bragg ◽  
...  
Author(s):  
N Chrestian ◽  
C Campbell ◽  
C Poulin ◽  
H McMillan ◽  
J Vajsar

Introduction: HNPP presentation in childhood is rare and diverse and most of the published literature is based on case reports. Materials and Methods: we analyzed the data of 11 children with deletion in PMP22 gene, reviewed the published reports of HNPP in children and compared our data with the reports from the literature review. Results: Peroneal palsy was the most common presentation (50%) followed by the brachial plexus palsy in 30% of cases. The trigger of the demyelinating event was identified only in 27%. 72% of our cohort developed only one acute episode of nerve palsy. Nerve conduction studies were always suggestive of the diagnosis demonstrating 60% of cases a polyneuropathy, 50% of cases conduction block but 100% of bilateral or unilateral electrophysiologic entrapment of the median nerve at the carpal tunnel. Conclusion: The clinical presentation of HNPP in childhood is heterogeneous and EMG findings are abnormal. Any unexplained mononeuropathy or multifocal neuropathy should lead to PMP22 gene testing to look for the deletion. Early diagnosis is important for the genetic counselling but also for the appropriate care of these patients.


2009 ◽  
Vol 56 (4) ◽  
Author(s):  
Izabela Moszyńska ◽  
Dagmara Kabzińska ◽  
Elena Sinkiewicz-Darol ◽  
Andrzej Kochański

Hereditary neuropathy with liability to pressure palsies (HNPP) is manifested by a spectrum of phenotypes, from the classical HNPP course associated with intermittent nerve palsies to a neuropathy resembling Charcot-Marie-Tooth type 1 (CMT1) disease. The majority of HNPP cases are associated with submicroscopical deletions in the 17p11.2-p12 region containing the PMP22 gene, while PMP22 point mutations are rare, representing about 15% of HNPP cases. In this study, we present a patient manifesting with atypical HNPP phenotype associated with a new Thr99fsX110 mutation in the PMP22 gene. We conclude that all patients who fulfill the electrophysiological criteria of HNPP, even if they lack the typical HNPP phenotype, should be tested for point mutations in the PMP22 gene.


2005 ◽  
Vol 15 (7) ◽  
pp. 493-497 ◽  
Author(s):  
H. Zéphir ◽  
T. Stojkovic ◽  
P. Latour ◽  
J.F. Hurtevent ◽  
F. Blankaert ◽  
...  

2002 ◽  
Vol 12 (7-8) ◽  
pp. 651-655 ◽  
Author(s):  
R.A.C van de Wetering ◽  
A.A.W.M Gabreëls-Festen ◽  
V Timmerman ◽  
G.W Padberg ◽  
F.J.M Gabreëls ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document